Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer.
Journal Information
Full Title: Lipids Health Dis
Abbreviation: Lipids Health Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nutrition & Dietetics
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis work was approved by the ethics committee of Hunan Cancer Hospital (ethics: no. SBQLL-2021-092) All recruited subjects provided informed consent by signing consent forms prior to participating in the experiment. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported by the science and technology innovation Program of Hunan Province (2021SK51101, 2021SK51103)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025